Pre-transfusion platelet counts and bleeding in very low birth weight infants

Elizabeth F Stone1, Rebecca Birch2, Jeanne E Hendrickson3,4

  • 1Department of Pathology & Cell Biology, Columbia University Irving Medical Center, New York, NY, USA. es2024@cumc.columbia.edu.

Insights

Platelet transfusion thresholds for premature infants are similar regardless of bleeding status. However, very premature infants with severe intraventricular hemorrhage had higher pre-transfusion platelet counts.

Area of Science:

  • Neonatal Medicine
  • Hematology
  • Pediatric Critical Care

Background:

  • Platelet transfusion thresholds for very low birth weight (VLBW) infants (<1500g) lack standardization.
  • The impact of bleeding on optimal platelet transfusion strategies in VLBW infants remains unclear.

Purpose of the Study:

  • To investigate the relationship between bleeding and pre-transfusion platelet counts in VLBW infants.
  • To determine if bleeding influences the platelet counts required for transfusion in this vulnerable population.

Main Methods:

  • An observational birth cohort study included 210 VLBW infants requiring platelet transfusions within 3 weeks of birth.
  • Mixed-effects linear regression models analyzed pre-transfusion platelet counts in infants with and without bleeding, including specific analysis for severe intraventricular hemorrhage (IVH).

Main Results:

  • Most transfused VLBW infants (76%) experienced bleeding, with IVH being the most common type (61%).
  • No significant difference in pre-transfusion platelet counts was observed between infants with and without bleeding diagnoses (56.3 vs 58.5 × 10³ /µL).
  • Infants with severe IVH exhibited higher pre-transfusion platelet counts (68.9 × 10³ /µL) compared to the overall cohort (53.5 × 10³ /µL).

Conclusions:

  • Pre-transfusion platelet counts do not differ significantly between VLBW infants with or without bleeding diagnoses.
  • Severe intraventricular hemorrhage is associated with higher pre-transfusion platelet counts in VLBW infants, suggesting potential differences in transfusion needs.
Abstract

Related Concept Videos

Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Blood Transfusion and Agglutination02:45

Blood Transfusion and Agglutination

Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Structure and Function of Platelets01:18

Structure and Function of Platelets

The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...